Key Signaling Pathways in the Muscle-Invasive Bladder Carcinoma: Clinical Markers for Disease Modeling and Optimized Treatment

International Journal of Cancer - United States
doi 10.1002/ijc.29918
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma

Cancers
Cancer ResearchOncology
2019English

Correction To: SEOM Clinical Guideline for Treatment of Muscle-Invasive and Metastatic Urothelial Bladder Cancer (2016)

Clinical and Translational Oncology
MedicineCancer ResearchOncology
2019English

Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2019English

Surveillance and Treatment of Non-Muscle-Invasive Bladder Cancer in the USA

Advances in Urology
GynecologyUrologyObstetrics
2012English

Advances in Intravesical Therapy for the Treatment of Non-Muscle Invasive Bladder Cancer (Review)

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Collagen Stiffness Promoted Non-Muscle-Invasive Bladder Cancer Progression to Muscle-Invasive Bladder Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Parallel Proteomic Analysis in Muscle-Invasive Bladder Transitional Cell Carcinoma and Cancer-Related Stroma

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Achieving the Achievable in Muscle-Invasive Bladder Cancer

Journal of the Canadian Urological Association
OncologyUrology
2012English

HER2/neu Overexpression in the Development of Muscle-Invasive Transitional Cell Carcinoma of the Bladder

British Journal of Cancer
Cancer ResearchOncology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy